Renal Disease Treatment Market - Global Outlook and Forecast 2023-2028

Report ID: 1369703 | Published Date: Jan 2025 | No. of Page: 68 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Renal Disease Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Renal Disease Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Renal Disease Treatment Overall Market Size
    2.1 Global Renal Disease Treatment Market Size: 2021 VS 2028
    2.2 Global Renal Disease Treatment Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Renal Disease Treatment Players in Global Market
    3.2 Top Global Renal Disease Treatment Companies Ranked by Revenue
    3.3 Global Renal Disease Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Renal Disease Treatment Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Renal Disease Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Renal Disease Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Renal Disease Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Renal Disease Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Renal Disease Treatment Market Size Markets, 2021 & 2028
        4.1.2 Acute Kidney Problems
        4.1.3 Chronic Kidney Diseases
        4.1.4 Others
    4.2 By Type - Global Renal Disease Treatment Revenue & Forecasts
        4.2.1 By Type - Global Renal Disease Treatment Revenue, 2017-2022
        4.2.2 By Type - Global Renal Disease Treatment Revenue, 2023-2028
        4.2.3 By Type - Global Renal Disease Treatment Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Renal Disease Treatment Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Clinic
        5.1.4 Research Center
        5.1.5 Other
    5.2 By Application - Global Renal Disease Treatment Revenue & Forecasts
        5.2.1 By Application - Global Renal Disease Treatment Revenue, 2017-2022
        5.2.2 By Application - Global Renal Disease Treatment Revenue, 2023-2028
        5.2.3 By Application - Global Renal Disease Treatment Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Renal Disease Treatment Market Size, 2021 & 2028
    6.2 By Region - Global Renal Disease Treatment Revenue & Forecasts
        6.2.1 By Region - Global Renal Disease Treatment Revenue, 2017-2022
        6.2.2 By Region - Global Renal Disease Treatment Revenue, 2023-2028
        6.2.3 By Region - Global Renal Disease Treatment Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Renal Disease Treatment Revenue, 2017-2028
        6.3.2 US Renal Disease Treatment Market Size, 2017-2028
        6.3.3 Canada Renal Disease Treatment Market Size, 2017-2028
        6.3.4 Mexico Renal Disease Treatment Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Renal Disease Treatment Revenue, 2017-2028
        6.4.2 Germany Renal Disease Treatment Market Size, 2017-2028
        6.4.3 France Renal Disease Treatment Market Size, 2017-2028
        6.4.4 U.K. Renal Disease Treatment Market Size, 2017-2028
        6.4.5 Italy Renal Disease Treatment Market Size, 2017-2028
        6.4.6 Russia Renal Disease Treatment Market Size, 2017-2028
        6.4.7 Nordic Countries Renal Disease Treatment Market Size, 2017-2028
        6.4.8 Benelux Renal Disease Treatment Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Renal Disease Treatment Revenue, 2017-2028
        6.5.2 China Renal Disease Treatment Market Size, 2017-2028
        6.5.3 Japan Renal Disease Treatment Market Size, 2017-2028
        6.5.4 South Korea Renal Disease Treatment Market Size, 2017-2028
        6.5.5 Southeast Asia Renal Disease Treatment Market Size, 2017-2028
        6.5.6 India Renal Disease Treatment Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Renal Disease Treatment Revenue, 2017-2028
        6.6.2 Brazil Renal Disease Treatment Market Size, 2017-2028
        6.6.3 Argentina Renal Disease Treatment Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Renal Disease Treatment Revenue, 2017-2028
        6.7.2 Turkey Renal Disease Treatment Market Size, 2017-2028
        6.7.3 Israel Renal Disease Treatment Market Size, 2017-2028
        6.7.4 Saudi Arabia Renal Disease Treatment Market Size, 2017-2028
        6.7.5 UAE Renal Disease Treatment Market Size, 2017-2028
7 Players Profiles
    7.1 Abbott
        7.1.1 Abbott Corporate Summary
        7.1.2 Abbott Business Overview
        7.1.3 Abbott Renal Disease Treatment Major Product Offerings
        7.1.4 Abbott Renal Disease Treatment Revenue in Global Market (2017-2022)
        7.1.5 Abbott Key News
    7.2 Amgen
        7.2.1 Amgen Corporate Summary
        7.2.2 Amgen Business Overview
        7.2.3 Amgen Renal Disease Treatment Major Product Offerings
        7.2.4 Amgen Renal Disease Treatment Revenue in Global Market (2017-2022)
        7.2.5 Amgen Key News
    7.3 Baxter
        7.3.1 Baxter Corporate Summary
        7.3.2 Baxter Business Overview
        7.3.3 Baxter Renal Disease Treatment Major Product Offerings
        7.3.4 Baxter Renal Disease Treatment Revenue in Global Market (2017-2022)
        7.3.5 Baxter Key News
    7.4 Bristol-Myers Squibb Company
        7.4.1 Bristol-Myers Squibb Company Corporate Summary
        7.4.2 Bristol-Myers Squibb Company Business Overview
        7.4.3 Bristol-Myers Squibb Company Renal Disease Treatment Major Product Offerings
        7.4.4 Bristol-Myers Squibb Company Renal Disease Treatment Revenue in Global Market (2017-2022)
        7.4.5 Bristol-Myers Squibb Company Key News
    7.5 Keryx Biopharmaceuticals
        7.5.1 Keryx Biopharmaceuticals Corporate Summary
        7.5.2 Keryx Biopharmaceuticals Business Overview
        7.5.3 Keryx Biopharmaceuticals Renal Disease Treatment Major Product Offerings
        7.5.4 Keryx Biopharmaceuticals Renal Disease Treatment Revenue in Global Market (2017-2022)
        7.5.5 Keryx Biopharmaceuticals Key News
    7.6 NephroGenex
        7.6.1 NephroGenex Corporate Summary
        7.6.2 NephroGenex Business Overview
        7.6.3 NephroGenex Renal Disease Treatment Major Product Offerings
        7.6.4 NephroGenex Renal Disease Treatment Revenue in Global Market (2017-2022)
        7.6.5 NephroGenex Key News
    7.7 Novartis AG
        7.7.1 Novartis AG Corporate Summary
        7.7.2 Novartis AG Business Overview
        7.7.3 Novartis AG Renal Disease Treatment Major Product Offerings
        7.7.4 Novartis AG Renal Disease Treatment Revenue in Global Market (2017-2022)
        7.7.5 Novartis AG Key News
    7.8 Pfizer
        7.8.1 Pfizer Corporate Summary
        7.8.2 Pfizer Business Overview
        7.8.3 Pfizer Renal Disease Treatment Major Product Offerings
        7.8.4 Pfizer Renal Disease Treatment Revenue in Global Market (2017-2022)
        7.8.5 Pfizer Key News
    7.9 Sanofi
        7.9.1 Sanofi Corporate Summary
        7.9.2 Sanofi Business Overview
        7.9.3 Sanofi Renal Disease Treatment Major Product Offerings
        7.9.4 Sanofi Renal Disease Treatment Revenue in Global Market (2017-2022)
        7.9.5 Sanofi Key News
    7.10 Shire Pharmaceuticals Limited
        7.10.1 Shire Pharmaceuticals Limited Corporate Summary
        7.10.2 Shire Pharmaceuticals Limited Business Overview
        7.10.3 Shire Pharmaceuticals Limited Renal Disease Treatment Major Product Offerings
        7.10.4 Shire Pharmaceuticals Limited Renal Disease Treatment Revenue in Global Market (2017-2022)
        7.10.5 Shire Pharmaceuticals Limited Key News
    7.11 CTI BioPharma Corp
        7.11.1 CTI BioPharma Corp Corporate Summary
        7.11.2 CTI BioPharma Corp Business Overview
        7.11.3 CTI BioPharma Corp Renal Disease Treatment Major Product Offerings
        7.11.4 CTI BioPharma Corp Renal Disease Treatment Revenue in Global Market (2017-2022)
        7.11.5 CTI BioPharma Corp Key News
    7.12 Merck
        7.12.1 Merck Corporate Summary
        7.12.2 Merck Business Overview
        7.12.3 Merck Renal Disease Treatment Major Product Offerings
        7.12.4 Merck Renal Disease Treatment Revenue in Global Market (2017-2022)
        7.12.5 Merck Key News
    7.13 Prolong Pharmaceuticals
        7.13.1 Prolong Pharmaceuticals Corporate Summary
        7.13.2 Prolong Pharmaceuticals Business Overview
        7.13.3 Prolong Pharmaceuticals Renal Disease Treatment Major Product Offerings
        7.13.4 Prolong Pharmaceuticals Renal Disease Treatment Revenue in Global Market (2017-2022)
        7.13.5 Prolong Pharmaceuticals Key News
    7.14 VESSL Therapeutics
        7.14.1 VESSL Therapeutics Corporate Summary
        7.14.2 VESSL Therapeutics Business Overview
        7.14.3 VESSL Therapeutics Renal Disease Treatment Major Product Offerings
        7.14.4 VESSL Therapeutics Renal Disease Treatment Revenue in Global Market (2017-2022)
        7.14.5 VESSL Therapeutics Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Renal Disease Treatment Market Opportunities & Trends in Global Market
    Table 2. Renal Disease Treatment Market Drivers in Global Market
    Table 3. Renal Disease Treatment Market Restraints in Global Market
    Table 4. Key Players of Renal Disease Treatment in Global Market
    Table 5. Top Renal Disease Treatment Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Renal Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Renal Disease Treatment Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Renal Disease Treatment Product Type
    Table 9. List of Global Tier 1 Renal Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Renal Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Renal Disease Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Renal Disease Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Renal Disease Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Renal Disease Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Renal Disease Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Renal Disease Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Renal Disease Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Renal Disease Treatment Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Renal Disease Treatment Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Renal Disease Treatment Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Renal Disease Treatment Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Renal Disease Treatment Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Renal Disease Treatment Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Renal Disease Treatment Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Renal Disease Treatment Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Renal Disease Treatment Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Renal Disease Treatment Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Renal Disease Treatment Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Renal Disease Treatment Revenue, (US$, Mn), 2023-2028
    Table 30. Abbott Corporate Summary
    Table 31. Abbott Renal Disease Treatment Product Offerings
    Table 32. Abbott Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 33. Amgen Corporate Summary
    Table 34. Amgen Renal Disease Treatment Product Offerings
    Table 35. Amgen Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 36. Baxter Corporate Summary
    Table 37. Baxter Renal Disease Treatment Product Offerings
    Table 38. Baxter Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 39. Bristol-Myers Squibb Company Corporate Summary
    Table 40. Bristol-Myers Squibb Company Renal Disease Treatment Product Offerings
    Table 41. Bristol-Myers Squibb Company Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 42. Keryx Biopharmaceuticals Corporate Summary
    Table 43. Keryx Biopharmaceuticals Renal Disease Treatment Product Offerings
    Table 44. Keryx Biopharmaceuticals Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 45. NephroGenex Corporate Summary
    Table 46. NephroGenex Renal Disease Treatment Product Offerings
    Table 47. NephroGenex Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 48. Novartis AG Corporate Summary
    Table 49. Novartis AG Renal Disease Treatment Product Offerings
    Table 50. Novartis AG Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 51. Pfizer Corporate Summary
    Table 52. Pfizer Renal Disease Treatment Product Offerings
    Table 53. Pfizer Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 54. Sanofi Corporate Summary
    Table 55. Sanofi Renal Disease Treatment Product Offerings
    Table 56. Sanofi Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 57. Shire Pharmaceuticals Limited Corporate Summary
    Table 58. Shire Pharmaceuticals Limited Renal Disease Treatment Product Offerings
    Table 59. Shire Pharmaceuticals Limited Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 60. CTI BioPharma Corp Corporate Summary
    Table 61. CTI BioPharma Corp Renal Disease Treatment Product Offerings
    Table 62. CTI BioPharma Corp Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 63. Merck Corporate Summary
    Table 64. Merck Renal Disease Treatment Product Offerings
    Table 65. Merck Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 66. Prolong Pharmaceuticals Corporate Summary
    Table 67. Prolong Pharmaceuticals Renal Disease Treatment Product Offerings
    Table 68. Prolong Pharmaceuticals Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 69. VESSL Therapeutics Corporate Summary
    Table 70. VESSL Therapeutics Renal Disease Treatment Product Offerings
    Table 71. VESSL Therapeutics Renal Disease Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Renal Disease Treatment Segment by Type in 2021
    Figure 2. Renal Disease Treatment Segment by Application in 2021
    Figure 3. Global Renal Disease Treatment Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Renal Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Renal Disease Treatment Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Renal Disease Treatment Revenue in 2021
    Figure 8. By Type - Global Renal Disease Treatment Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Renal Disease Treatment Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Renal Disease Treatment Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Renal Disease Treatment Revenue Market Share, 2017-2028
    Figure 12. US Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Renal Disease Treatment Revenue Market Share, 2017-2028
    Figure 16. Germany Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 17. France Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Renal Disease Treatment Revenue Market Share, 2017-2028
    Figure 24. China Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 28. India Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Renal Disease Treatment Revenue Market Share, 2017-2028
    Figure 30. Brazil Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Renal Disease Treatment Revenue Market Share, 2017-2028
    Figure 33. Turkey Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Renal Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 37. Abbott Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Amgen Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Baxter Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Bristol-Myers Squibb Company Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Keryx Biopharmaceuticals Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. NephroGenex Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Novartis AG Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Pfizer Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Sanofi Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Shire Pharmaceuticals Limited Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. CTI BioPharma Corp Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Merck Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Prolong Pharmaceuticals Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. VESSL Therapeutics Renal Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
68
Frequently Asked Questions
Renal Disease Treatment Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Renal Disease Treatment Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Renal Disease Treatment Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports